$295 Million is the total value of Tavio Capital LLC's 17 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 91.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DGX | New | QUEST DIAGNOSTICS INC | $39,866,000 | – | 362,612 | +100.0% | 13.50% | – |
| ANTM | Sell | ANTHEM INC | $39,164,000 | +0.3% | 164,532 | -7.5% | 13.26% | -28.0% |
| ABC | New | AMERISOURCEBERGEN CORP | $27,891,000 | – | 327,089 | +100.0% | 9.44% | – |
| CVS | Buy | CVS HEALTH CORP | $27,671,000 | +12.5% | 430,000 | +8.8% | 9.37% | -19.2% |
| CNC | New | CENTENE CORP DEL | $20,773,000 | – | 168,596 | +100.0% | 7.03% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $20,476,000 | +54.8% | 164,933 | +39.0% | 6.93% | +11.2% |
| HCA | Buy | HCA HEALTHCARE INC | $20,245,000 | +60.6% | 197,318 | +51.9% | 6.86% | +15.4% |
| HUM | Sell | HUMANA INC | $15,843,000 | -10.0% | 53,232 | -18.7% | 5.36% | -35.4% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $14,235,000 | -27.2% | 435,330 | -39.2% | 4.82% | -47.7% |
| HRTX | Sell | HERON THERAPEUTICS INC | $10,751,000 | +10.7% | 276,729 | -21.3% | 3.64% | -20.5% |
| UNH | New | UNITEDHEALTH GROUP INC | $10,411,000 | – | 42,435 | +100.0% | 3.53% | – |
| AET | New | AETNA INC NEW | $10,156,000 | – | 55,346 | +100.0% | 3.44% | – |
| MOH | Sell | MOLINA HEALTHCARE INC | $10,013,000 | -62.4% | 102,238 | -68.9% | 3.39% | -73.0% |
| CELG | New | CELGENE CORP | $9,960,000 | – | 125,408 | +100.0% | 3.37% | – |
| RTRX | RETROPHIN INC | $8,012,000 | +21.9% | 293,923 | 0.0% | 2.71% | -12.5% | |
| FOLD | New | AMICUS THERAPEUTICS INC | $6,294,000 | – | 402,955 | +100.0% | 2.13% | – |
| ZGNX | New | ZOGENIX INC | $3,543,000 | – | 80,160 | +100.0% | 1.20% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -111,967 | -100.0% | -6.25% | – |
| DVA | Exit | DAVITA INC | $0 | – | -213,772 | -100.0% | -6.65% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -241,546 | -100.0% | -7.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
| CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
| ANTHEM INC | 10 | Q2 2019 | 22.5% |
| BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
| RETROPHIN INC | 9 | Q1 2019 | 3.4% |
| ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
| HUMANA INC | 8 | Q4 2019 | 37.8% |
| UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
| HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
| MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-10-01 |
| 13F-HR | 2020-08-13 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-13 |
| 13F-HR | 2019-08-13 |
| 13F-HR | 2019-05-14 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.